Evaluation of the Patient-ventilator Asynchrony During Mechanical Ventilation for Pediatric Acute Respiratory Failure

Sponsor
St. Justine's Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03138148
Collaborator
(none)
60
1
79.4
0.8

Study Details

Study Description

Brief Summary

The synchronization between the patient and the ventilator is an essential objective during mechanical ventilation (MV). Maintaining the patient's respiratory activity during MV reduces ventilation pressures, improves oxygenation, and decreases sedation. In order to do this, the inspiratory or expiratory effort of the patient must be detected by the respirator' sensor systems, so that the assistance delivered by the respirator is coordinated with the patient's respiratory cycles. The usual systems do not actually detect the beginning of the effort but its result: variation in flow rate or pressure at the respirator circuit, which depends on the patient's respiratory mechanics and sensitivity of the sensor. This detection is currently imperfect, which generates asynchrony between the patient's needs and the assistance of the respirator. The asynchrony comprises the periods of delay between the beginning of the inspiration (or expiration) and the response of the respirator, but also of the unsuitable cycles: inspiratory efforts of the patient not detected by the respirator, or inversely triggering assistance in the absence of inspiration by the patient (self-initiation), or delivery of 2 cycles of assistance for a single inspiration (double triggering).

Asynchrony is a risk factor for prolonged mechanical ventilation in adults. Adult studies have shown that patient-ventilator asynchrony is common during MV, and is associated with prolonged MV duration. An association with length of stay in intensive care and in hospital was also observed. In children, patient-ventilator synchronization is more difficult to achieve than in adults due to a higher respiratory rate and smaller current volumes. The impact of patient-ventilator asynchrony on evolution has not been studied in pediatrics.

Patient-ventilator synchronization could be improved by the development of new ventilatory modes. The new NAVA (neurally adjusted ventilatory assist) ventilation mode detects the patient's breathing efforts earlier by monitoring the electrical activity of the diaphragm through the esophagus. This new mode seems to improve synchronization in children. NAVA ventilation may therefore be a step forward, but its clinical benefits remain to be seen.

The objective of this study is to evaluate the impact of patient-ventilator asynchrony on the duration of mechanical ventilation in children with acute respiratory failure.

Condition or Disease Intervention/Treatment Phase
  • Other: Routine mechanical ventilation

Study Design

Study Type:
Observational
Actual Enrollment :
60 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of the Patient-ventilator Asynchrony During Mechanical Ventilation for Pediatric Acute Respiratory Failure
Actual Study Start Date :
May 26, 2010
Actual Primary Completion Date :
Oct 17, 2012
Actual Study Completion Date :
Jan 6, 2017

Arms and Interventions

Arm Intervention/Treatment
Severe patient-ventilator asynchrony

Patients in whom the total percentage of time spent in asynchrony is superior to the entire cohort's 75th percentile

Other: Routine mechanical ventilation
Routine mechanical ventilation in PICU amid children with acute respiratory failure

less severe patient-ventilator asynchrony

Patients in whom the total percentage of time spent in asynchrony is inferior to the entire cohort's 75th percentile

Other: Routine mechanical ventilation
Routine mechanical ventilation in PICU amid children with acute respiratory failure

Outcome Measures

Primary Outcome Measures

  1. Difference in ventilator free days [28 days]

    Difference in ventilator free days at Day 28th between the two patient groups (high versus moderate asynchrony)

Secondary Outcome Measures

  1. The impact of asynchrony on Comfort scale [at inclusion]

    Comfort Scale between the two patient groups (high versus moderate asynchrony)

  2. Intensive care unit length of stay [28 days]

    between the two patient groups (high versus moderate asynchrony)

  3. Mortality in pediatric intensive care unit [28 days]

    between the two patient groups (high versus moderate asynchrony)

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Month to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Mechanical ventilation planned for more than 24h according to the physician in charge;

  • Presence of a spontaneous respiratory activity (defined by the presence of respiratory cycles activated by the patient);

  • Parental consent obtained with the parents or with the legal representative.

Exclusion Criteria:
  • pathologies for which a long and difficult weaning of the mechanical ventilation is expected: chronic respiratory failure with history of ventilation superior to one month, severe neurological or muscular pathology;

  • Patients with a tracheotomy;

  • Patients receiving a treatment by curare;

  • Contraindication of recording of the diaphragmatic activity by oesophageal way, in particular recent oesophageal surgery, oesophageal stenosis, suspicion of diaphragmatic paralysis, severe coagulation disorder;

  • Patients to whom a death seems imminent;

  • Patients for whom a limitation of the care was considered.

Contacts and Locations

Locations

Site City State Country Postal Code
1 St. Justine's Hospital Montreal Quebec Canada H3T 1C5

Sponsors and Collaborators

  • St. Justine's Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr Guillaume Emeriaud, Principal Investigator, Intensivist, Clinical Associate Professor, St. Justine's Hospital
ClinicalTrials.gov Identifier:
NCT03138148
Other Study ID Numbers:
  • CHUSJ-3113
First Posted:
May 3, 2017
Last Update Posted:
May 5, 2017
Last Verified:
May 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr Guillaume Emeriaud, Principal Investigator, Intensivist, Clinical Associate Professor, St. Justine's Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 5, 2017